The Rate and Importance of Clostridium Difficile in Colorectal Cancer Patients Publisher



Jahanisherafat S^{1, 2} ; Azimirad M² ; Alebouyeh M² ; Amoli HA³ ; Hosseini P⁴ ; Ghasemiansafaei H¹ ; Moghim S¹ Show Affiliations
Source: Gastroenterology and Hepatology from Bed to Bench Published:2019

Abstract

Aim: The aim of this study was to analyze the Clostridium difficile and their toxins in cancerous tissues in comparison to their adjacent healthy tissues in patients with colorectal cancer (CRC) in Iran. Background: Intestinal infection or colonization by microbial pathogens and their released metabolites may have a role in the exacerbation of CRC. Methods: A total of 60 biopsy samples from 30 cancerous and 30 adjacent healthy tissues were collected from patients with CRC. Biopsies were homogenized and cultured in cycloserine cefoxitin fructose agar-agar medium to investigate the presence of C. difficile. DNA was extracted, PCR was performed on pure colonies for bacteria detection, and toxin genes were evaluated in each bacterium positive cases. Real-time PCR was performed on extracted DNA for quantitative comparison of Clostridium difficile in healthy and tumor tissues in CRC patients. Results: Clostridium difficile was isolated from 18 of the cancerous tissue (60%) and 6 of their healthy adjacent tissue (20%) in the culture medium, but toxin genes were positive just in one sample in both groups. Real-time PCR showed the colonization in all samples. Conclusion: This study showed a higher prevalence of Clostridium difficile in cancerous lesions in comparison to healthy tissues. We suggest that the investigation of the rate of CD of colorectal cancer patients before surgery is critical for patients. Further studies with more samples size to study the importance of this bacterium and its toxins in the investigation of colorectal cancer patients survey is recommended. © 2019 RIGLD, Research Institute for Gastroenterology and Liver Diseases.